LAVI Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Lavipharm SA

Watchlist Manager

Watchlist

Price: 1.568 EUR 1.16% Market Closed

Market Cap: €267.8m

L	Lavipharm SA ATHEX:LAVI	GR
T	Tongda Group Holdings Ltd HKEX:698	HK
	Dubber Corp Ltd ASX:DUB	AU
	Barratt Redrow PLC OTC:BTDPF	UK
T	Tecnicas Reunidas SA MAD:TRE	ES
	One REIT Inc TSE:3290	JP
P	Plotech Co Ltd TWSE:6141	TW
	Multi Commodity Exchange of India Ltd NSE:MCX	IN
	Barito Pacific Tbk PT IDX:BRPT	ID
X	Xero Ltd SWB:0XE	NZ
	Trek Metals Ltd ASX:TKM	BM
	Teekay Corp NYSE:TK	BM
E	Essilorluxottica SA DUS:ESL	FR
	Maywufa Co Ltd TWSE:1731	TW
	Link Net Tbk PT IDX:LINK	ID

Profitability Summary

Lavipharm SA's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

47%

Sustainable 3Y Average Gross Margin

47%

Gross Margin is Increasing

40% > 47%

Healthy Operating Margin

14%

Sustainable 3Y Average Operating Margin

12%

Operating Margin is Increasing

9% > 14%

Low Net Margin

Low 3Y Average Net Margin

10%

Net Margin is Increasing

2% > 8%

Negative Free Cash Flow Margin

-12%

Negative 3Y Average Free Cash Flow Margin

-7%

Free Cash Flow Margin is Increasing

-62% > -12%

Positive ROE

10%

Positive 3Y Average ROE

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.